GlassScriptPhysician profile
David William Dockray
NPI 1538455399
$5,329.92
in general payments reported to CMS, 2019-2025
39 companies · $478 in 2025
The $478 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,748 · 2020: $407 · 2021: $342 · 2022: $471 · 2023: $340 · 2024: $544 · 2025: $478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,361.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,500.00 | 2019 | |
| Silk Road Medical, INC. | $773.25 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Endologix LLC | $740.28 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $266.52 | 2020-2022 | |
| Boston Scientific Corporation | $255.02 | 2022-2025 | Ranger, Enroute Transcarotid Neuroprotection System, Eluvia |
| Pfizer INC. | $191.07 | 2019-2025 | |
| Stryker Corporation | $163.79 | 2025 | Flowtriever, Artix Mt, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $137.54 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Cvrx, INC. | $132.49 | 2022-2025 | Barostim Neo System |
| Smith+Nephew, INC. | $117.26 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $116.33 | 2019-2023 | Venovo |
| W. L. Gore & Associates, INC. | $101.33 | 2023 | Gore Tag Thoracic Branch Endoprosthesis |
| Tactile Systems Technology INC | $94.14 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Cardiovascular Systems INC. | $65.11 | 2019-2022 | |
| Edwards Lifesciences Corporation | $61.99 | 2019-2024 | Mitris Resilia Mitral Valve |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $52.65 | 2019-2025 | Vasoview Hemopro 2 |
| Inari Medical, INC. | $51.40 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Philips North America LLC | $41.89 | 2023 | |
| Covidien LP | $38.69 | 2019 | |
| Teleflex LLC | $37.86 | 2020-2025 | Manta |
| Terumo Medical Corporation | $37.06 | 2022 | |
| Bolton Medical INC | $35.66 | 2022-2023 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Angiodynamics, INC. | $31.63 | 2019-2023 | Alphavac |
| Surmodics, INC. | $30.95 | 2024-2025 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Microcatheter, 018, 200cm, Straight, Pounce Thrombectomy |
| Avinger INC. | $28.83 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $23.95 | 2022 | |
| Amgen INC. | $21.81 | 2022 | |
| Ethicon US, LLC | $20.93 | 2025 | Ethicon, Vistaseal, Prolene |
| Ucb, INC. | $18.86 | 2024 | Cimzia |
| Cardiva Medical, INC. | $17.04 | 2023 | Cardiva Vascade 6/7f Vcs |
| Ekos Corporation | $16.93 | 2019 | |
| Cook Medical LLC | $16.42 | 2022 | |
| Alexion Pharmaceuticals, INC. | $16.12 | 2021 | |
| Stemline Therapeutics INC. | $15.65 | 2025 | Orserdu |
| Conmed Corporation | $14.79 | 2024 | Visiclear |
| Medtronic, INC. | $14.28 | 2022 | |
| Lemaitre Vascular, INC. | $12.60 | 2023 | Artegraft Vascular Graft |
| Venturemed Group, INC. | $11.40 | 2021 | |
| Vasorum USA INC. | $6.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dockray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.